3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 2/3
2
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Endometrial Neoplasms
2
Interventions
Cisplatin
22
Magnetic Resonance Spectroscopy
18
Gemcitabine
15
Carboplatin
14
pembrolizumab
13
Specimen Handling
13
Paclitaxel
13
Radiotherapy
10
Nivolumab
10
Bevacizumab
10
atezolizumab
8
Radiation
8
Platinum
8
Pemetrexed
8
Doxorubicin
8
Docetaxel
8
1,2-diaminocyclohexaneplatinum II citrate
8
Drug Therapy
7
Dexamethasone
7
Temozolomide
6
Rituximab
6
Radiotherapy, Intensity-Modulated
6
Prednisone
6
Surgical Procedures, Operative
5
Ipilimumab
5
Immunoglobulin G
5
Disulfides
5
Cytarabine
5
Cyclophosphamide
5
Biopsy
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Medroxyprogesterone Acetate
×
90 days
×
Clear all
NCT05255653
2026-05-15
RAINBO
Leiden University Medical Center
Phase 2/3
Recruiting
1,615 enrolled
NCT07319429
2026-03-13
FEMUS
Fudan University
Phase 2/3
Recruiting
260 enrolled